sub:assertion {
  d:DB01224 v:identifier "DB01224" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB01224" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB01224> ;
    dv:drugbank-id "APRD00675" , "DB01224" ;
    dv:x-ahfs <http://bio2rdf.org/ahfs:28:16.08.04> ;
    dv:x-atc <http://bio2rdf.org/atc:N05AH04> ;
    dv:x-cas <http://bio2rdf.org/cas:111974-69-7> ;
    dv:x-chebi <http://bio2rdf.org/chebi:8707> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:4827> ;
    dv:x-dpd <http://bio2rdf.org/dpd:2240862> ;
    dv:x-gtp <http://bio2rdf.org/gtp:50> ;
    dv:x-iuphar <http://bio2rdf.org/iuphar:50> ;
    dv:x-kegg <http://bio2rdf.org/kegg:C07397> ;
    dv:x-ndc <http://bio2rdf.org/ndc:0310-0275-10> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA451201> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:5002> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46504800> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Quetiapine> ;
    dct:description "Quetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder. The antipsychotic effect of quetiapine is thought by some to be mediated through antagonist activity at dopamine and serotonin receptors. Specifically the D1 and D2 dopamine, the alpha 1 adrenoreceptor and alpha 2 adrenoreceptor, and 5-HT1A and 5-HT2 serotonin receptor subtypes are antagonized. Quetiapine also has an antagonistic effect on the histamine H1 receptor."@en ;
    dct:identifier "drugbank:DB01224" ;
    dct:title "Quetiapine"@en ;
    a dv:Drug ;
    rdfs:label "Quetiapine [drugbank:DB01224]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB01224> , <http://www.drugs.com/cdi/quetiapine.html> , <http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/ser1402.shtml> , <http://www.rxlist.com/cgi/generic2/quetiap.htm> .
}